Dr. Peter Attia

And biology is the messiest of the sciences. So with that stated, I think there are some high probability certainties out there with respect to vaccine. I think there were some really gray areas and I think everybody needs to ask the question, what am I optimizing for? So I will start that question with you, right? What is it you are most afraid of as you think about vaccinating your kids?

And biology is the messiest of the sciences. So with that stated, I think there are some high probability certainties out there with respect to vaccine. I think there were some really gray areas and I think everybody needs to ask the question, what am I optimizing for? So I will start that question with you, right? What is it you are most afraid of as you think about vaccinating your kids?

And biology is the messiest of the sciences. So with that stated, I think there are some high probability certainties out there with respect to vaccine. I think there were some really gray areas and I think everybody needs to ask the question, what am I optimizing for? So I will start that question with you, right? What is it you are most afraid of as you think about vaccinating your kids?

What is the mistake you're worried about? What are you afraid of and what are you hoping to achieve?

What is the mistake you're worried about? What are you afraid of and what are you hoping to achieve?

What is the mistake you're worried about? What are you afraid of and what are you hoping to achieve?

So let's just take those two examples. I think the second one's a lot easier because I think the answer there is I would put it a little more in the more certainty category. Although I think the previous one as well we can address. So when it comes to the COVID vaccine, one of the concerns, particularly with the mRNA vaccines and particularly more so with the Moderna one than the Pfizer one was,

So let's just take those two examples. I think the second one's a lot easier because I think the answer there is I would put it a little more in the more certainty category. Although I think the previous one as well we can address. So when it comes to the COVID vaccine, one of the concerns, particularly with the mRNA vaccines and particularly more so with the Moderna one than the Pfizer one was,

So let's just take those two examples. I think the second one's a lot easier because I think the answer there is I would put it a little more in the more certainty category. Although I think the previous one as well we can address. So when it comes to the COVID vaccine, one of the concerns, particularly with the mRNA vaccines and particularly more so with the Moderna one than the Pfizer one was,

you saw an above the baseline increase in myocarditis, in particular in young men. So myocarditis is an inflammation of the cardiac muscle. Now, you always have to remember when you're vaccinating millions of people, there's going to be background noise. People get myocarditis all the time. And you can get any sort of viral infection and get myocarditis.

you saw an above the baseline increase in myocarditis, in particular in young men. So myocarditis is an inflammation of the cardiac muscle. Now, you always have to remember when you're vaccinating millions of people, there's going to be background noise. People get myocarditis all the time. And you can get any sort of viral infection and get myocarditis.

you saw an above the baseline increase in myocarditis, in particular in young men. So myocarditis is an inflammation of the cardiac muscle. Now, you always have to remember when you're vaccinating millions of people, there's going to be background noise. People get myocarditis all the time. And you can get any sort of viral infection and get myocarditis.

I've known countless people and seen in the hospital and been around people who have got myocarditis for no reason other than they got an infection. So you have to know there's a baseline level of this going on. But it really appeared that in particular for young men, teenagers and in their 20s perhaps, there was an uptick. following that particular vaccine in the incidence of myocarditis.

I've known countless people and seen in the hospital and been around people who have got myocarditis for no reason other than they got an infection. So you have to know there's a baseline level of this going on. But it really appeared that in particular for young men, teenagers and in their 20s perhaps, there was an uptick. following that particular vaccine in the incidence of myocarditis.

I've known countless people and seen in the hospital and been around people who have got myocarditis for no reason other than they got an infection. So you have to know there's a baseline level of this going on. But it really appeared that in particular for young men, teenagers and in their 20s perhaps, there was an uptick. following that particular vaccine in the incidence of myocarditis.

To be clear, most of those men recovered without event. I think that the real mistake of policymakers at the time, because this would have been about 2022, was not acknowledging that, right? Like to acknowledge that is basically to say, hey, this is biomedical science.

To be clear, most of those men recovered without event. I think that the real mistake of policymakers at the time, because this would have been about 2022, was not acknowledging that, right? Like to acknowledge that is basically to say, hey, this is biomedical science.

To be clear, most of those men recovered without event. I think that the real mistake of policymakers at the time, because this would have been about 2022, was not acknowledging that, right? Like to acknowledge that is basically to say, hey, this is biomedical science.

Things happen and we don't always know when we do studies on a few thousand people, what's gonna happen when it reaches a million people. Because if the signal is so small that it's only 0.1% of people, you're not going to pick that up at a thousand. You gotta be able to do a million and you're not gonna do that until it's out in the real world. So why not just acknowledge that and say, hey,

Things happen and we don't always know when we do studies on a few thousand people, what's gonna happen when it reaches a million people. Because if the signal is so small that it's only 0.1% of people, you're not going to pick that up at a thousand. You gotta be able to do a million and you're not gonna do that until it's out in the real world. So why not just acknowledge that and say, hey,